OUN87710


Catalog No. size PriceQuantity
M7085-2 2mg solid $150
M7085-10 10mg solid $603

Description

Cas:502887-71-0

Product Information

OUN87710, also known as MMP-9-IN-1 is a specific matrix metalloproteinase-9 (MMP-9) inhibitor. OUN87710 was first reported by Antoine Dufour et al (Cancer Res. 2011, 71(14): 4977–4988, compound 2). OUN87710 has CAS#502887-71-0, no formal name For the convenience of scientific communication, we named it as OUN87710combined from Inchi key plus CAS#) according to Hodoodo Chemical Nomenclature.

 

Chemical Formula: C16H17F2N3O3S

 

Exact Mass: 369.0959

Molecular Weight: 369.3868

 

Elemental Analysis: C, 52.03; H, 4.64; F, 10.29; N, 11.38; O, 12.99; S, 8.68

 

Synonym:

 

MMP-9-IN-1

MMP-9-IN1

MMP9-IN-1

OUN87710

OUN-87710

OUN 87710

 

Chemical Name: N-(4-(difluoromethoxy)phenyl)-2-((6-oxo-4-propyl-1,6-dihydropyrimidin-2-yl)thio)acetamide

 

InChi Key: 

OLTRRVUORWPRGF-UHFFFAOYSA-N

 

InChi Code: InChI=1S/C16H17F2N3O3S/c1-2-3-11-8-13(22)21-16(20-11)25-9-14(23)19-10-4-6-12(7-5-10)24-15(17)18/h4-8,15H,2-3,9H2,1H3,(H,19,23)(H,20,21,22)

 

Smiles Code:

O=C(NC1=CC=C(OC(F)F)C=C1)CSC2=NC(CCC)=CC(N2)=O

 

 

Technical Data:

 

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

 

In Vitro:

MMP-9-IN-1 (compound 2; 100 μM; 14 hours) does not cause notable cytotoxicity.

MMP-9-IN-1 (compound 2; 10 μM) significantly inhibits cell proliferation of HT-1080 and MDA-MB-435 cells.

 

In Vivo:

MMP-9-IN-1 (compound 2; 20 mg/kg; intraperitoneal and intratumoral injection alternately; 6 days/week; for 14 weeks) results in a profound delay in tumor growth in NCR-Nu mice bearing MDA-MB-435/GFP tumor.

MMP-9-IN-1 inhibits cancer cell metastasis in vivo.

 

 

References

 

  1. Dufour A, et al. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9. Cancer Res. 2011 Jul 15;71(14):4977-88.

 

Products are for research use only. Not for human use.

Payment & Security

American Express Apple Pay Diners Club Discover Elo Google Pay JCB Mastercard PayPal Shop Pay Venmo Visa

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed